Scadenza: 26 April 2022
Topic:
Validate non-invasive, or minimally invasive cancer screening and detection methodologies for everyday medical practice and population-based screening programmes93, including enhanced participation of the target population. These programmes should become faster, more precise and personalised, affordable and accessible.
Programma:
Mission Cancer
Ente finanziatore:
EU
Budget complessivo:
60.00 million
Who can participate:
To be eligible for funding, applicants must be established in one of the eligible countries, i.e.:
– the Member States of the European Union, including their outermost regions;
– the Overseas Countries and Territories (OCTs) linked to the Member States;
– eligible non-EU countries:
– countries associated to Horizon Europe;
– low- and middle-income countries
Partnership: Mandatory
Status:
Closed
Quota finanziabile:
100%
Topic:
Validate non-invasive, or minimally invasive cancer screening and detection methodologies for everyday medical practice and population-based screening programmes93, including enhanced participation of the target population. These programmes should become faster, more precise and personalised, affordable and accessible.
Who can participate:
To be eligible for funding, applicants must be established in one of the eligible countries, i.e.:
– the Member States of the European Union, including their outermost regions;
– the Overseas Countries and Territories (OCTs) linked to the Member States;
– eligible non-EU countries:
– countries associated to Horizon Europe;
– low- and middle-income countries
Programme:
Mission Cancer
Consortium: Required
Status: Open
Total budget:
60.00 million
Funding rate:
100%
Notes:
Expected stage at project start: Technological Readiness Level 4 and above.
The Commission estimates that an EU contribution of between EUR 4.00 and 15.00 million would allow these outcomes to be addressed appropriately.
